LAI GOLDMAN MYLA 4
4 · Akoya Biosciences, Inc. · Filed Sep 20, 2021
Insider Transaction Report
Form 4
LAI GOLDMAN MYLA
Director
Transactions
- Award
Stock Option (Right to Buy
2021-09-16+38,993→ 38,993 totalExercise: $18.10Exp: 2031-09-16→ Common Stock (38,993 underlying)
Footnotes (1)
- [F1]Subject to the reporting person's continuous service through the vesting date, the options shall vest in three (3) equal installments beginning on September 16, 2022 and annually thereafter until fully vested.